Animal Models of Type 2 Diabetes, Obesity and Nonalcoholic Steatohepatitis – Clinical Translatability and Applicability in Preclinical Drug Development
Authors:
- 2 April 2019
- book chapter
- Published by Springer Nature
- p. 369-403
Abstract
No abstract availableKeywords
This publication has 288 references indexed in Scilit:
- A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinomaMedical Molecular Morphology, 2013
- Central Nervous System Mechanisms Linking the Consumption of Palatable High-Fat Diets to the Defense of Greater AdiposityCell Metabolism, 2012
- The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetesDiabetologia, 2011
- Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failureDiabetologia, 2010
- Obesity and leptin resistance: distinguishing cause from effectTrends in Endocrinology & Metabolism, 2010
- Mouse models for Type 1 DiabetesDrug Discovery Today: Disease Models, 2009
- The mechanisms of alloxan- and streptozotocin-induced diabetesDiabetologia, 2007
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Little or No Expression of the Cholecystokinin-A Receptor Gene in the Pancreas of Diabetic Rats (Otsuka Long-Evans Tokushima Fatty=OLETF Rats)Biochemical and Biophysical Research Communications, 1994
- Hyperinsulinemia in pre-weaning diabetes (db) miceDiabetologia, 1974